Clinical Trial Update: Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ) [NA]

View source ↗

Summary

This clinical trial update reports completion of a study evaluating Tandem's Control-IQ technology in high insulin users with Type 1 diabetes, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Control-IQ Technology

Snippet

Sponsor: Tandem Diabetes Care, Inc. | Conditions: Type 1 Diabetes | NA | Status: COMPLETED | Results posted: 2024-04-17